Application no. and date | 13772420.9 (espacenet) (Federated) (European Patent Register), 20130313 | Patent/reg. no. and date | DK/EP 2760285, 20170621 | Publication date | 20140806 | Priority no. and date | US 201261620107 P, 20120404 | EP pub. no. and date |
EP 2760285 20140806 | Effective date | | Applicant/owner | BioSplice Therapeutics, Inc., 9360 Towne Centre Drive
San Diego, CA 92121, US | Applicant ref. no. | YOU P104724EP/GAD | Inventor | HOOD, John, 10831 Vereda Sol del Dios
San Diego, CA 92130, US, WALLACE, David, Mark, 6448 Peinado Way
San Diego, CA 92121, US, KC, Sunil, Kumar, 10504 Clasico Court
San Diego, CA 92127, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/437 (2006.01) , A61K 31/444 (2006.01) , A61K 31/4545 (2006.01) , A61K 31/496 (2006.01) , A61K 31/5377 (2006.01) , A61P 19/00 (2006.01) , A61P 25/28 (2006.01) , A61P 31/10 (2006.01) , A61P 31/12 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | Title | INDAZOLINHIBITORER AF WNT-SIGNALVEJEN OG TERAPEUTISKE ANVENDELSER DERAF | Int. application no. | US2013031055 | Int. publication no. | WO2013151708 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|